About the Authors
- Mette Ilander
-
Affiliation Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
- Anna Kreutzman
-
Affiliation Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
- Peter Rohon
-
Affiliation Department of Hemato-Oncology, Faculty Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- Teresa Melo
-
Affiliation Hospital de S. Joao, Porto, Portugal
- Edgar Faber
-
Affiliation Department of Hemato-Oncology, Faculty Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
- Kimmo Porkka
-
Affiliation Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
- Jukka Vakkila
-
Affiliation Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
- Satu Mustjoki
-
* E-mail: satu.mustjoki@helsinki.fi
Affiliation Hematology Research Unit Helsinki, Department of Medicine, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
Competing Interests
Kimmo Porkka and Satu Mustjoki have received research funding and honoraria from Novartis and Bristol-Myers Squibb, but these are not related to this study. These conflict of interests do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MI AK KP JV SM. Performed the experiments: MI. Analyzed the data: MI AK KP JV SM. Contributed reagents/materials/analysis tools: PR EF TM SM KP. Wrote the paper: MI AK KP JV SM.